Journals / Mikrobiyoloji Bülteni / 2007 / Cilt: 41 - Sayı: 4

Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Türkey

Antalya'da sitomegalovirus seroepidemiyolojinin toplum kaynaklı kesitsel bir çalışma ile araştırılması ve Türkiye verilerinin derlenmesi

Pages
545–555
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall seroprevalence of CMV-IgG was found as 93.6% (337/360) in Antalya municipality and IgM positivity was not detected in CMV-IgG negative sera.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since there are numerous studies on CMV seroprevalence in various groups in Turkey, the number of population based, age-stratified cross-sectional studies which include epidemiological characteristics of the virus are limited.
📊
Key Findings & Data:The sample size was calculated as 360 subjects (151 male, 209 female; age range: 1-49 years, mean age: 22.5±14.4 years), with an expected prevalence rate of 80%, at a confidence level of 95% and a sample error less than 5%.
💡
Conclusion & Impact:The overall seroprevalence of CMV-IgG was found as 93.6% (337/360) in Antalya municipality and IgM positivity was not detected in CMV-IgG negative sera.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Since there are numerous studies on CMV seroprevalence in various groups in Turkey, the number of population based, age-stratified cross-sectional studies which include epidemiological characteristics of the virus are limited. The aim of the study was to investigate the age-stratified seroprevalence and epidemiological characteristics of CMV infection in Antalya (a province located in Mediterranean region of Turkey). Study group was selected by cluster sampling method. The sample size was calculated as 360 subjects (151 male, 209 female; age range: 1-49 years, mean age: 22.5±14.4 years), with an expected prevalence rate of 80%, at a confidence level of 95% and a sample error less than 5%. With the thought of the presence of maternal antibodies, 0-1 year age group was not included to the study. Serum samples have been screened for CMV-IgG, and those given negative results were also searched for CMV-IgM by a commercial microELISA (Radim, Italy) test. The overall seroprevalence of CMV-IgG was found as 93.6% (337/360) in Antalya municipality and IgM positivity was not detected in CMV-IgG negative sera. An increase in the seroprevalence rates was observed with age (p<0.001), and the rate was found quite high (93.3%) for the first year of life. The seropositivities in the age groups of 1-6, 7-14 and 14-49 years were detected as 82.1%, 92% and 97.8%, respectively. The seroprevalence rate of 82.1% before the age of seven has rised to 96.8% after that age, and being &#8805;7 years old was found statistically significant in terms of CMV infection (p<0.001, OR: 6.635). Ages one and seven were found to be the critical ages for CMV infection in our region. CMV seropositivity was 97.4% in woman at childbearing age (15-49 years). Gender, marital status, education, living area, residence, income, history of sexually transmitted diseases, surgery, blood transfusion and day care attendance did not contribute independently to the seroepidemiology of CMV (p>0.01). In addition, the data of this study were evaluated and discussed together with the results obtained from the other Turkish studies, as far as accessible. In conclusion, since CMV seroepidemiology in Turkey differs as the socioeconomic changes occur, the changes in CMV serostatus and dire consequences of high seroprevalence rates on public health should be evaluated with prospective, population based studies in further years.

Özet

Türkiye’de çeşitli gruplarda sitomegalovirus (CMV) seroprevalansının araştırıldığı çok sayıda çalışma olmasına rağmen, virusun epidemiyolojik özelliklerini de içeren toplum temelli, yaş tabakalandırmalı kesitsel çalışma sayısı oldukça sınırlıdır. Bu çalışmanın amacı, CMV enfeksiyonunun Antalya kent merkezinde yaş tabakalandırmalı seroprevalans oranının ve epidemiyolojik özelliklerinin belirlenmesidir. Çalışma grubu küme örnekleme yöntemi ile seçilmiş; örneklem büyüklüğü %95 güvenlik aralığı içinde, hata oranı %5’den az olacak şekilde ve beklenen prevalans oranı %80 kabul edilerek hesaplanmış ve 360 kişi (151 erkek, 209 kadın; yaş aralığı: 1-49 yıl, yaş ortalaması: 22.5±14.4 yıl) olarak belirlenmiştir. Maternal antikor varlığı olasılığı nedeniyle 0-1 yaş grubu çalışmaya alınmamıştır. Serum örneklerinde önce CMV-IgG ticari bir mikroELISA yöntemi (Radim, İtalya) ile araştırılmış, negatif olan örnekler CMV-IgM varlığı yönünden incelenmiştir. Antalya kent merkezinde CMV-IgG seroprevalansı %93.6 (337/360) olarak saptanmış, CMV-IgG negatif serum örneklerinin hiçbirinde CMV-IgM belirlenmemiştir. Seropozitifliğin yaşa bağlı olarak arttığı izlenmiş (p 0.01).

🔖

Cite This Article

ATAMAN, Ş., ÇOLAK, D., GÜNSEREN, F., ÇOLAK, T., ŞENOL, Y., AKTEKİN, M. R., GÜLTEKİN, M. (2007). Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Türkey. Mikrobiyoloji Bülteni, Cilt: 41 - Sayı: 4, 545–555. https://ajindex.com/articles/299643

References (16)

  1. de Jong MD, Galasso GJ, Gazzard B, et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998; 39: 141-62
  2. Pass RF, Hutto C. Group day care and cytomegaloviral infections of mothers and children. Rev Infect Dis 1986; 8: 599-605
  3. Yow MD, White NH, Taber LH, et al. Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study. J Pediatr 1987; 110: 37-42
  4. Gaynant MA, Steegers EAP, Semmekrot BA, Merkus HMMW, Galama JMD. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Survey 2002; 57: 245-56
  5. Almeide LNB, Azevedo RS, Amaku M, Massad E. Cytomegalovirus seroepidemiology in an urban community of Sao Paulo, Brasil. Rev Sau Publica 2001; 35: 124-9
  6. Aarnisalo J, Ilonen J, Vainionpää R, Velanen I, Kaitosaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis 2003; 35: 750-2
  7. White NH, Yow MD, Demler GJ, et al. Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 years. J Infect Dis 1989; 159: 1013-17
  8. Erçakmak F, Alaçam R, Ustaçelebi Ş. İntrakraniyal tümörlü hasta serumlarında herpes simplex tip 1, tip 2, sitomegalovirus ve adenovirus grubuna karşı antikorların prevalansı. Türk Viroloji Dergisi 1969; 1: 167-70
  9. Günhan C. Ege bölgesinde sitomegalovirus (CMV) enfeksiyonunun epidemiyolojik durumu. Ege Üni Tıp Fak Mec 1971; 10: 425-8
  10. Alacam R. A study on the prevalence of cytomegalovirus complement-fixing antibodies in the Turkish population. Mikrobiyol Bul 1980; 14: 47-52
  11. Ustacelebi S, Koksal I, Canturk H, Saify SJ, Ersoz D, Sellioglu B. Detection of antibodies against TORCH agents during pregnancy. Mikrobiyol Bul 1986; 20: 1-8
  12. Ozek B, Ustacelebi S, Durmus Z, Büyükkagnici U, Aral K, Aydogdu A. Cytomegalovirus infections in pregnant women. Mikrobiyol Bul 1989; 23: 292-301
  13. Tüzün Hİ, Bilgiç A, Erensoy E. İzmir bölgesinde anti-sitomegalovirus prevalansı. İnfeksiyon Derg 1991; 5: 269-72
  14. Cengiz AT, Ataoğlu H, Anter U. Sitomegalovirus IgG antikorlarının ELISA ile kan donörleri serumunda gösterilmesi. Infeksiyon Derg 1990; 4: 609-15
  15. Cengiz AT, Cengiz L, Ataoğlu H, Kıyan M, Aksoy E. Sağlıklı doğum yapan annenin serumunda ve bebeğin kordon serumunda CMV IgG antikorlarının araştırılması. Türk Mikrobiyol Cem Derg 1990; 20: 176-81
  16. Durupınar B,